Artificial Pancreas: In Silico Study Shows No Need of Meal Announcement and Improved Time in Range of Glucose With Intraperitoneal vs. Subcutaneous Insulin Delivery
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Contemporary Artificial Pancreas (AP) consists of a subcutaneous (SC) glucose sensor, a SC insulin pump and a control algorithm. Even the most advanced systems are far from optimal, in particular due to the non-physiologic nature of SC route. While SC insulin delivery is convenient and minimally invasive, it introduces delays to insulin action that make tight control difficult, particularly during meals. In addition frequent patient interventions are needed, e.g., at mealtime. The intraperitoneal (IP) insulin delivery could address this major challenge since it exhibits a faster pharmacokinetics/pharmacodynamics, hence making easier to quickly respond to glycemic disturbances. A 1-day hospital closed-loop study has shown significant improvements of IP glucose control vs SC AP, and that meal announcement is not necessary. However, the IP AP has not been tested in more realistic everyday life conditions. In this work we have performed an in silico study of 14 days of an IP AP by using the UVA/Padova simulator which includes intra- and inter-day variability of insulin sensitivity and several real life scenarios. We show superiority of IP AP vs SC AP in terms of quality of glucose control (time in range 87% IP vs 80% SC) without the need of a meal announcement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“D IABETES mellitus is a life-threatening disease and its global prevalence is dramatically increasing as a result of population ageing, urbanization and associated lifestyle changes [1], [2].”
BackgroundThe worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227 · cited 1×
“D IABETES mellitus is a life-threatening disease and its global prevalence is dramatically increasing as a result of population ageing, urbanization and associated lifestyle changes [1], [2].”
BackgroundInternational consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069 · cited 1×
“The performance metrics used in this work has been selected following the consensus endpoints for AP trial described in [48], [49].”
MethodSelf-citationIncidence trends of type 1 and type 2 diabetes among youths, 2002–2012
Mayer-Davis, E. J., Lawrence, J. M., Dabelea, D., Divers, J., Isom, S., Dolan, L., Imperatore, G., Linder, B., Marcovina, S., Pettitt, D. J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610187 · Cited by 1,476
Epidemiology of depression and diabetes: a systematic review
Roy, T., & Lloyd, C. E. (2012) · Journal of Affective Disorders · doi:10.1016/s0165-0327(12)70004-6 · Cited by 1,229 · cited 1×
“These and other disease associated burden triplicates depression in T1D subjects [8].”
BackgroundSix-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
Brown, S. A., Kovatchev, B. P., Raghinaru, D., Lum, J. W., Buckingham, B. A., Kudva, Y. C., Laffel, L. M., Levy, C. J., Pinsker, J. E., Wadwa, R. P., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1907863 · Cited by 1,030 · cited 1×
“The results obtained with MPC-SC-A are in agreement with several AP studies, including the most recent state-of-art trial [50].”
ResultAchievement of Goals in U.S. Diabetes Care, 1999–2010
Ali, M. K., Bullard, K. M., Saaddine, J. B., Cowie, C. C., Imperatore, G., & Gregg, E. W. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1213829 · Cited by 979 · cited 1×
“It has been estimated that only about half of the patients meet the targets recommended by the scientific societies clinical guidelines [6] despite the exorbitant number of therapeutic actions (100.”
BackgroundMeal Simulation Model of the Glucose-Insulin System
Dalla Man, C., Rizza, R. A., & Cobelli, C. (2007) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2007.893506 · Cited by 955
Self-citationEstimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010
Livingstone, S. J., Levin, D., Looker, H. C., Lindsay, R. S., Wild, S. H., Joss, N., Leese, G., Leslie, P., McCrimmon, R. J., Metcalfe, W., et al. (2015) · JAMA · doi:10.1001/jama.2014.16425 · Cited by 621 · cited 1×
“which is still the most frequent cause of death in people with T1D aged under 50 years [7].”
BackgroundContinuous glucose monitoring and closed‐loop systems
Hovorka, R. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01672.x · Cited by 443
Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms
Doyle, F. J., Huyett, L. M., Lee, J. B., Zisser, H. C., & Dassau, E. (2014) · Diabetes Care · doi:10.2337/dc13-2108 · Cited by 394
Model Predictive Control of Type 1 Diabetes: An in Silico Trial
Magni, L., Raimondo, D. M., Bossi, L., Dalla Man, C., De Nicolao, G., Kovatchev, B., & Cobelli, C. (2007) · Journal of Diabetes Science and Technology · doi:10.1177/193229680700100603 · Cited by 317
Self-citationThe UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day
Visentin, R., Campos-Náñez, E., Schiavon, M., Lv, D., Vettoretti, M., Breton, M., Kovatchev, B. P., Dalla Man, C., & Cobelli, C. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818757747 · Cited by 280 · cited 4×
“The model used in the MPC is a linearization of the average model of the UVA/Padova simulator [40], [41] and no constraints are considered in order to allow a closed-form solution easily implementable on the devices.”
BackgroundMethodInfluentialSelf-citationHaidar, A., Legault, L., Messier, V., Mitre, T. M., Leroux, C., & Rabasa-Lhoret, R. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70226-8 · Cited by 214
Outcome measures for artificial pancreas clinical trials: a consensus report
Maahs, D. M., Buckingham, B. A., Castle, J. R., Cinar, A., Damiano, E. R., Dassau, E., DeVries, J. H., Doyle, F. J., Griffen, S. C., Haidar, A., et al. (2016) · Diabetes Care · doi:10.2337/dc15-2716 · Cited by 211
Kropff, J., Del Favero, S., Place, J., Toffanin, C., Visentin, R., Monaro, M., Messori, M., Di Palma, F., Lanzola, G., Farret, A., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00335-6 · Cited by 201
Self-citationRenard, E., Place, J., Cantwell, M., Chevassus, H., & Palerm, C. C. (2010) · Diabetes Care · doi:10.2337/dc09-1080 · Cited by 176
Haidar, A., Tsoukas, M. A., Bernier-Twardy, S., Yale, J.-F., Rutkowski, J., Bossy, A., Pytka, E., El Fathi, A., Strauss, N., & Legault, L. (2020) · Diabetes Care · doi:10.2337/dc19-1922 · Cited by 138
Ly, T. T., Roy, A., Grosman, B., Shin, J., Campbell, A., Monirabbasi, S., Liang, B., von Eyben, R., Shanmugham, S., Clinton, P., et al. (2015) · Diabetes Care · doi:10.2337/dc14-3073 · Cited by 132
MPC based Artificial Pancreas: Strategies for individualization and meal compensation
Soru, P., Nicolao, G. D., Toffanin, C., Man, C. D., Cobelli, C., & Magni, L. (2012) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2012.03.009 · Cited by 130
Self-citationToward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results
Toffanin, C., Visentin, R., Messori, M., Palma, F. D., Magni, L., & Cobelli, C. (2018) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2017.2652062 · Cited by 107
Self-citationArtificial Pancreas: Model Predictive Control Design from Clinical Experience
Toffanin, C., Messori, M., Di Palma, F., De Nicolao, G., Cobelli, C., & Magni, L. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700607 · Cited by 106
Self-citationRenard, E., Farret, A., Kropff, J., Bruttomesso, D., Messori, M., Place, J., Visentin, R., Calore, R., Toffanin, C., Di Palma, F., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0008 · Cited by 104
Self-citationDassau, E., Renard, E., Place, J., Farret, A., Pelletier, M., Lee, J., Huyett, L. M., Chakrabarty, A., Doyle, F. J., & Zisser, H. C. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12999 · Cited by 94
Del Favero, S., Place, J., Kropff, J., Messori, M., Keith‐Hynes, P., Visentin, R., Monaro, M., Galasso, S., Boscari, F., Toffanin, C., et al. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12440 · Cited by 90
Self-citationLiebl, A., Hoogma, R., Renard, E., Geelhoed‐Duijvestijn, P. H. L. M., Klein, E., Diglas, J., Kessler, L., Melki, V., Diem, P., Brun, J. ‐., et al. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01059.x · Cited by 83
Gin, H., Renard, É., Melki, V., Boivin, S., Schaepelynck-Belicar, P., Guerci, B., Jl, S., Brun, J. M., Riveline, J., Estour, B., et al. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70075-7 · Cited by 72
Implantable batteryless device for on-demand and pulsatile insulin administration
Lee, S. H., Lee, Y. B., Kim, B. H., Lee, C., Cho, Y. M., Kim, S.-N., Park, C. G., Cho, Y.-C., & Choy, Y. B. (2017) · Nature Communications · doi:10.1038/ncomms15032 · Cited by 68
Advances in artificial pancreas systems
Boughton, C. K., & Hovorka, R. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw4949 · Cited by 66
Saunders, A., Messer, L. H., & Forlenza, G. P. (2019) · Expert Review of Medical Devices · doi:10.1080/17434440.2019.1670639 · Cited by 62
Nathan, D. M., Dunn, F. L., Bruch, J. S., McKitrick, C., Larkin, M., Haggan, C., Lavin-Tompkins, J. M., Norman, D., Rogers, D., & Simon, D. A. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89516-2 · Cited by 60
Messori, M., Kropff, J., Del Favero, S., Place, J., Visentin, R., Calore, R., Toffanin, C., Di Palma, F., Lanzola, G., Farret, A., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0463 · Cited by 59
Self-citationDetermination of Portal Insulin Absorption From Peritoneum via Novel Nonisotopic Method
Selam, J.-L., Bergman, R. N., Raccah, D., Jean-Didier, N., Lozano, J., & Charles, M. A. (1990) · Diabetes · doi:10.2337/diab.39.11.1361 · Cited by 57
The year of transition from research to clinical practice
Kovatchev, B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.170 · Cited by 48
Do-It-Yourself Artificial Pancreas System and the OpenAPS Movement
Lewis, D. M. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.005 · Cited by 47
Toffanin, C., Aiello, E. M., Favero, S. D., Cobelli, C., & Magni, L. (2019) · Journal of Process Control · doi:10.1016/j.jprocont.2019.03.007 · Cited by 43
Self-citationIacovacci, V., Ricotti, L., Dario, P., & Menciassi, A. (2015) · IEEE/ASME Transactions on Mechatronics · doi:10.1109/tmech.2014.2327196 · Cited by 42
Jeandidier, N., Sélam, J.-L., Renard, É., Guerci, B., Lassman-Vague, V., Rocher, L., Hanaire, H. P., & The Evadiac Study Group (1996) · Diabetes Care · doi:10.2337/diacare.19.7.780 · Cited by 41
Glucose-insulin model identified in free-living conditions for hypoglycaemia prevention
Toffanin, C., Favero, S. D., Aiello, E. M., Messori, M., Cobelli, C., & Magni, L. (2018) · Journal of Process Control · doi:10.1016/j.jprocont.2018.02.003 · Cited by 39
Self-citationSchoelwer, M. J., Robic, J. L., Gautier, T., Fabris, C., Carr, K., Oliveri, M. C., Brown, S. A., Anderson, S. M., DeBoer, M. D., Cherñavvsky, D. R., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0471 · Cited by 35
Hedman, C. A., Frystyk, J., Lindström, T., Oskarsson, P., & Arnqvist, H. J. (2013) · Clinical Endocrinology · doi:10.1111/cen.12296 · Cited by 31
van Dijk, P. R., Groenier, K. H., DeVries, J. H., Gans, R. O. B., Kleefstra, N., Bilo, H. J. G., & Logtenberg, S. J. J. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0001 · Cited by 19
In vivo organ specific drug delivery with implantable peristaltic pumps
Speed, J. S., & Hyndman, K. A. (2016) · Scientific Reports · doi:10.1038/srep26251 · Cited by 19
Hypoglycemia Prevention via Personalized Glucose-Insulin Models Identified in Free-Living Conditions
Toffanin, C., Aiello, E. M., Cobelli, C., & Magni, L. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819880864 · Cited by 16
Self-citationBoering, M., van Dijk, P. R., Logtenberg, S. J. J., Groenier, K. H., Wolffenbuttel, B. H. R., Gans, R. O. B., Kleefstra, N., & Bilo, H. J. G. (2016) · Endocrine Connections · doi:10.1530/ec-16-0006 · Cited by 11
Miniaturized peristaltic rotary pump for non-continuous drug dosing
Tamadon, I., Simoni, V., Iacovacci, V., Vistoli, F., Ricotti, L., & Menciassi, A. (2019) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2019.8857811 · Cited by 11
van Dijk, P. R., Logtenberg, S. J. J., Chisalita, S. I., Hedman, C. A., Groenier, K. H., Gans, R. O. B., Kleefstra, N., Arnqvist, H. J., & Bilo, H. J. G. (2015) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2015.08.007 · Cited by 7
Use of intraperitoneal insulin delivery for artificial pancreas
Renard, É., Farret, A., & Place, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815655-1.00014-4 · Cited by 5
Research works printed but not linked: 1
- 2017, IDF Diabetes Atlas Eighth Edition
Cited by
iGLU 3.0: A Secure Noninvasive Glucometer and Automatic Insulin Delivery System in IoMT
Joshi, A. M., Jain, P., & Mohanty, S. P. (2022) · IEEE Transactions on Consumer Electronics · doi:10.1109/tce.2022.3145055 · Cited by 47
Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility
Cobelli, C., & Kovatchev, B. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231195081 · Cited by 46
Self-citationCai, D., Wu, W., Cescon, M., Liu, W., Ji, L., & Shi, D. (2023) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2023.100897 · Cited by 15
Lo Presti, J., Galderisi, A., Doyle, F. J., Zisser, H. C., Dassau, E., Renard, E., Toffanin, C., & Cobelli, C. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221076559 · Cited by 12
Self-citationConstrained Versus Unconstrained Model Predictive Control for Artificial Pancreas
Toffanin, C., & Magni, L. (2023) · IEEE Transactions on Control Systems Technology · doi:10.1109/tcst.2023.3291564 · Cited by 11
Self-citation
Metadata
- Authors
- Toffanin, C., Magni, L., & Cobelli, C.
- Affiliations
- University of Pavia (IT)
- University of Padua (IT)
- Venue
- IEEE Transactions on Medical Robotics and Bionics
- Published
- 2021-05
- Volume
- 3
- Issue
- 2
- Pages
- 306-314
- ISSN
- 2576-3202 (ISSN-L)
- OpenAlex
- W3157871157
- Cited by
- 22
- References
- 49
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 8 · 2022: 6 · 2021: 1
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- IEEE Transactions on Medical Robotics and Bionics (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Funders
- Italian Project PRIN15: “Forget Diabetes: Adaptive Physiological Artificial Pancreas”
- H2020-FETPROACT Project FORGETDIABETS (951933)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- artificial pancreas, subcutaneous insulin administration, time in range, glycemic control, computer simulation, UVA/Padova simulator
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.